sertraline has been researched along with Coronary Disease in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Benites-Zapata, VA; Brañez-Condorena, A; Chambergo-Michilot, D; Falvy-Bockos, I; Pacheco-Mendoza, J | 1 |
| Carney, RM; Freedland, KE; Harris, WS; Rich, MW; Rubin, EH; Steinmeyer, BC | 2 |
| Blumenthal, JA; Hinderliter, AL; Hoffman, BM; Sherwood, A; Smith, PJ; Watkins, LL | 1 |
| Angeloni, L; Costa, GM; Fontana, F; Mancini, S; Manzoli, L; Pizzi, C | 1 |
| Carney, RM; Freedland, KE; Harris, WS; Krone, RJ; Rich, MW; Rubin, EH; Stein, PK; Steinmeyer, BC | 1 |
| Bot, M; Carney, RM; Freedland, KE; Mann, DL; Rich, MW; Rubin, EH; Steinmeyer, BC | 1 |
| Carney, RM; de Jonge, P; Freedland, KE; Meyer, H; Roest, AM; Rubin, EH; Stein, PK; Steinmeyer, BC | 1 |
| Babyak, MA; Blumenthal, JA; Doraiswamy, PM; Hinderliter, AL; Hoffman, BM; Jiang, W; Johnson, J; Mabe, S; O'Hayer, CV; Schocken, DD; Sherwood, A; Smith, PJ; Watkins, LL | 1 |
| Gupta, S | 1 |
| Califf, RM; Finkel, MS; Gaffney, M; Glassman, AH; Harrison, W; Krishnan, KR; Malinin, AI; Musselman, DL; Nemeroff, CB; O'Connor, CM; Serebruany, VL; van Zyl, LT | 1 |
| Barton, D; Forman, LM; Gaffney, M; Glassman, AH; O'Connor, CM; Swedberg, K; Swenson, JR; Van Zyl, LT | 1 |
| Cooper, TB; Glassman, AH; Krishnan, KR; Lekht, V; Malinin, AI; O'Connor, CM; Serebruany, VL; Suckow, RF; van Zyl, LT | 1 |
| Bigger, JT; Gaffney, M; Glassman, AH; Shapiro, PA; Swenson, JR | 1 |
| Bigger, JT; Gaffney, M; Glassman, AH; Van Zyl, LT | 1 |
| Burg, MM; Cornell, CE; Cowan, MJ; Czajkowski, SM; Freedland, KE; Powell, LH; Saab, PG; Youngblood, ME | 1 |
| Iruela, LM | 1 |
| Gurbel, PA; O'Connor, CM; Serebruany, VL | 1 |
1 review(s) available for sertraline and Coronary Disease
| Article | Year |
|---|---|
Efficacy of omega-3 supplementation on sertraline continuous therapy to reduce depression or anxiety symptoms: A systematic review and meta-analysis.
Topics: Adult; Anxiety; Coronary Disease; Depression; Dietary Supplements; Fatty Acids, Omega-3; Humans; Sertraline; Treatment Outcome | 2021 |
14 trial(s) available for sertraline and Coronary Disease
| Article | Year |
|---|---|
A Randomized Placebo-Controlled Trial of Omega-3 and Sertraline in Depressed Patients With or at Risk for Coronary Heart Disease.
Topics: Antidepressive Agents; Coronary Disease; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dietary Supplements; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2019 |
Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial.
Topics: Adult; Combined Modality Therapy; Coronary Disease; Depressive Disorder, Major; Exercise Therapy; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease.
Topics: Aged; C-Reactive Protein; Coronary Disease; Depression; Double-Blind Method; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Vasodilation | 2009 |
Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
Topics: Antidepressive Agents; Comorbidity; Coronary Disease; Depressive Disorder, Major; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Drug Synergism; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Humans; Male; Middle Aged; Sertraline | 2009 |
Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease.
Topics: Circadian Rhythm; Comorbidity; Coronary Disease; Depressive Disorder; Drug Therapy, Combination; Electrocardiography, Ambulatory; Fatty Acids, Omega-3; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Sertraline; Treatment Outcome | 2010 |
Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.
Topics: Adult; Aged; Antidepressive Agents; Biomarkers; C-Reactive Protein; Coronary Disease; Depressive Disorder, Major; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease.
Topics: Antidepressive Agents; Coronary Disease; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Fatty Acids, Omega-3; Female; Heart Rate; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Sleep Apnea, Obstructive | 2012 |
Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study.
Topics: Aged; Antidepressive Agents; Comprehension; Coronary Disease; Depression; Exercise; Exercise Therapy; Humans; Male; Middle Aged; Prognosis; Sertraline; Treatment Outcome | 2012 |
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
Topics: Biomarkers; Blood Platelets; Coronary Disease; Depression; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome.
Topics: Acute Disease; Analysis of Variance; Antidepressive Agents; Coronary Disease; Depression; Female; Humans; Male; Middle Aged; Quality of Life; Regression Analysis; Sertraline; Treatment Outcome | 2003 |
Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.
Topics: Acute Disease; Ambulatory Care; Comorbidity; Coronary Disease; Depressive Disorder, Major; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Multivariate Analysis; Outpatient Clinics, Hospital; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.
Topics: Acute Disease; Affect; Arrhythmias, Cardiac; Comorbidity; Coronary Disease; Depressive Disorder, Major; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2007 |
Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial.
Topics: Adult; Aged; Antidepressive Agents; Assertiveness; Cognitive Behavioral Therapy; Combined Modality Therapy; Communication; Coronary Disease; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Personality Inventory; Sertraline; Social Support; Treatment Outcome | 2008 |
Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators.
Topics: Adult; Antidepressive Agents; Coronary Disease; Electrocardiography; Exercise Therapy; Female; Humans; Male; Patient Education as Topic; Prognosis; Psychology; Psychotherapy; Research Design; Risk Factors; Secondary Prevention; Sertraline; Surveys and Questionnaires; Survival Rate; United States | 2000 |
4 other study(ies) available for sertraline and Coronary Disease
| Article | Year |
|---|---|
Don't ignore heart-attack blues.
Topics: Antidepressive Agents; Coronary Disease; Depressive Disorder; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression.
Topics: Biomarkers; Blood Platelets; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Sudden chest pain with sertraline.
Topics: 1-Naphthylamine; Antidepressive Agents; Aspirin; Chest Pain; Coronary Disease; Depression; Humans; Male; Middle Aged; Nortriptyline; Propranolol; Sertraline | 1994 |
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.
Topics: Coronary Disease; Depression; Flow Cytometry; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, Cell Surface; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |